Gregory J. Riely, MD, PhD, on Identifying Patients With NTRK Fusions

Posted: Wednesday, September 1, 2021

Gregory J. Riely, MD, PhD, of Memorial Sloan Kettering Cancer Center, discusses some of the key issues in identifying patients whose tumors harbor NTRK fusions, including the types of tests to perform, the types of disease that should be tested, as well as the need for broad testing.